First Bank & Trust Cytokinetics Inc Transaction History
First Bank & Trust
- $510 Million
- Q3 2024
A detailed history of First Bank & Trust transactions in Cytokinetics Inc stock. As of the latest transaction made, First Bank & Trust holds 6,722 shares of CYTK stock, worth $337,578. This represents 0.07% of its overall portfolio holdings.
Number of Shares
6,722
Previous 6,757
0.52%
Holding current value
$337,578
Previous $366,000
3.28%
% of portfolio
0.07%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding CYTK
# of Institutions
410Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$737 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$591 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$487 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$390 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$324 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.73B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...